Cargando…

N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2

COVID-19, a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread across the globe. Predisposing factors such as age, diabetes, cardiovascular disease, and lowered immune function increase the risk of disease severity. T cell exhaustion, high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poe, Francis L., Corn, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261085/ https://www.ncbi.nlm.nih.gov/pubmed/32504923 http://dx.doi.org/10.1016/j.mehy.2020.109862

Ejemplares similares

Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes
por: Gibson, Kyle R, et al.
Publicado: (2011)

N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro
por: Milara, Javier, et al.
Publicado: (2022)

Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)

The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
por: Akhter, Javed, et al.
Publicado: (2021)

Inhibition of the Cell Uptake of Delta and Omicron SARS-CoV-2 Pseudoviruses by N-Acetylcysteine Irrespective of the Oxidoreductive Environment
por: La Maestra, Sebastiano, et al.
Publicado: (2022)

N-Acetylcysteine as a Potential Antidote and Biomonitoring Agent of Methylmercury Exposure
por: Aremu, David A., et al.
Publicado: (2008)

Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
por: Nasi, Aikaterini, et al.
Publicado: (2020)

The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2
por: Shagufta, et al.
Publicado: (2021)

Synthesis of Novel N(4)-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents
por: Amblard, Franck, et al.
Publicado: (2022)

Exploration of In-silico screening of therapeutic agents against SARS-CoV-2
por: Thakur, Yamini, et al.
Publicado: (2021)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

Potential Therapeutic Target and Vaccines for SARS-CoV-2
por: Hussain, Mohamed A., et al.
Publicado: (2023)

Therapeutic potential of compounds targeting SARS-CoV-2 helicase
por: Halma, Matthew T. J., et al.
Publicado: (2022)

Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection
por: Krishna, Gayathri, et al.
Publicado: (2020)

Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafish
por: Faria, Melissa, et al.
Publicado: (2019)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

Natural therapeutics against SARS CoV2: the potentiality and challenges
por: Bhar, Anirban, et al.
Publicado: (2022)

Brève : Sars-CoV-2, agent diabétogène ?
por: Dalmat, Yann-Mickael
Publicado: (2021)

EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus
por: Tsvetkov, Vladimir, et al.
Publicado: (2021)

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
por: Santos, Jennifer, et al.
Publicado: (2020)

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Petrak, Russell M., et al.
Publicado: (2021)

Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection
por: Liang, Weizheng, et al.
Publicado: (2022)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
por: Gupta, Ishita, et al.
Publicado: (2020)

Potential drug targets of SARS-CoV-2: From genomics to therapeutics
por: Shamsi, Anas, et al.
Publicado: (2021)

Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection
por: Shchetinin, Evgeny, et al.
Publicado: (2022)

Breastfeeding importance and its therapeutic potential against SARS‐CoV‐2
por: Vasques da Costa, Aline, et al.
Publicado: (2021)

SARS-CoV-2-induced senescence as a potential therapeutic target
por: Denholm, Mary, et al.
Publicado: (2022)

Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection
por: Banu, Sarena, et al.
Publicado: (2022)

SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
por: Zhou, Shilin, et al.
Publicado: (2023)

EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
por: Chourasia, Mukesh, et al.
Publicado: (2021)

Natural coumarins as potential anti-SARS-CoV-2 agents supported by docking analysis
por: Abdelmohsen, Usama Ramadan, et al.
Publicado: (2021)

Publisher Correction: Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafish
por: Faria, Melissa, et al.
Publicado: (2020)

Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
por: Rao, Praveen P. N., et al.
Publicado: (2021)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Therapeutic approaches for SARS-CoV-2 infection
por: Gupta, Ankur, et al.
Publicado: (2021)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fethq8nc6u10c3gc7bha76fmi9